BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8632315)

  • 21. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
    Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of morphine antinociception by antagonism of H2 receptors in the periaqueductal gray.
    Hough LB; Nalwalk JW
    Brain Res; 1992 Aug; 588(1):58-66. PubMed ID: 1356588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of guinea pig ileum contractions mediated by a class of histamine receptor resembling the H3 subtype.
    Trzeciakowski JP
    J Pharmacol Exp Ther; 1987 Dec; 243(3):874-80. PubMed ID: 2826760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency.
    Reidemeister S; Stark H; Ligneau X; Ganellin CR; Schwartz JC; Schunack W
    Pharmazie; 2000 Feb; 55(2):83-6. PubMed ID: 10723763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining the histamine H2-receptor in brain: the interaction with LSD.
    Green JP; Weinstein H; Maayani S
    NIDA Res Monogr; 1978; (22):38-59. PubMed ID: 30911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
    Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin.
    Clark EA; Hill SJ
    Eur J Pharmacol; 1996 Jan; 296(2):223-5. PubMed ID: 8838460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoregulation of enterochromaffin-like cell histamine secretion via the histamine 3 receptor subtype.
    Kidd M; Tang LH; Miu K; Lawton GP; Sandor A; Modlin IM
    Yale J Biol Med; 1996; 69(1):9-19. PubMed ID: 9041685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A quantitative analysis of histamine H2-receptor-mediated relaxation of rabbit trachea.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1982 Feb; 220(2):353-7. PubMed ID: 6120227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of histamine H1- and H2-receptors in guinea-pig left atrial membranes by [3H]-mepyramine and [3H]-tiotidine binding.
    Hattori Y; Endou M; Gando S; Kanno M
    Br J Pharmacol; 1991 Jun; 103(2):1573-9. PubMed ID: 1909203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric antisecretory and pharmacologic properties of N,N-dimethyl-N'-(2-diisopropylaminoethyl)-N-(4,6-dimethyl-2-pyridyl)ur ea (L-634,366).
    Torchiana ML; Cook PG; Hanson CA; Wesley CA; Westrick BL; Wiese SR; Risley EA; Williams M
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):120-33. PubMed ID: 2875693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for histamine and H2-receptors in opioid antinociception.
    Gogas KR; Hough LB; Eberle NB; Lyon RA; Glick SD; Ward SJ; Young RC; Parsons ME
    J Pharmacol Exp Ther; 1989 Aug; 250(2):476-84. PubMed ID: 2547933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resultant action of cimetidine in a cardiac adenylate cyclase assay: its elucidation by concentration-ratios analysis.
    Trist DG; Leff P; Black J; Gerskowitch VP; Shankley NP
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1043-7. PubMed ID: 3694525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
    Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
    Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of histamine receptor antagonists on antinociceptive action of narcotic analgesics.
    Malec D
    Pol J Pharmacol Pharm; 1987; 39(3):229-35. PubMed ID: 2894018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of histamine on intracortical blood vessels of rats].
    Zhao JJ; Liu Y; Chen XL; Liu JX; Tian YF; Zhang PB; Kang QY; Qiu F; Yang PB
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1284-7. PubMed ID: 16982436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection by cimetidine, but not ranitidine, implies that H2 receptors do not mediate arrhythmogenesis in a rat model of regional ischaemia and reperfusion in vitro.
    Banning MM; Curtis MJ
    Cardiovasc Res; 1995 Nov; 30(5):705-10. PubMed ID: 8595616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist.
    Hough LB; Nalwalk JW; Phillips JG; Kern B; Shan Z; Wentland MP; de Esch IJ; Janssen E; Barr T; Stadel R
    Neuropharmacology; 2007 Apr; 52(5):1244-55. PubMed ID: 17336343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antinociceptive activity of derivatives of improgran and burimamide.
    Hough LB; Nalwalk JW; Leurs R; Menge WM; Timmerman H
    Pharmacol Biochem Behav; 2000 Jan; 65(1):61-6. PubMed ID: 10638637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.